Pulmonary hypertension in patients with chronic myeloproliferative disorders

Research output: Contribution to journalArticlepeer-review


Pulmonary hypertension (PH) is a major complication of several haematological disorders. Chronic myeloproliferative diseases (CMPDs) associated with pulmonary hypertension have been included in group five of the clinical classification for pulmonary hypertension, corresponding to pulmonary hypertension for which the aetiology is unclear and/or multifactorial. The aim of this review is to discuss the epidemiology, pathogenic mechanism and treatment approaches of the more common forms of pulmonary hypertension in the context of CMPD’s: chronic thromboembolic pulmonary hypertension, precapillary pulmonary hypertension and drug-induced PH.

Original languageEnglish
Pages (from-to)400-410
Number of pages11
JournalEuropean Respiratory Review
Issue number137
Publication statusPublished - Sep 1 2015

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Pulmonary hypertension in patients with chronic myeloproliferative disorders'. Together they form a unique fingerprint.

Cite this